Relationship between CD44 expression and differentiation of human prostate adenocarcinomas

Cancer Letters

Volumn 129, Issue 1, 1998, Pages 97-102

  Takahashi, Satoru ^a   Kimoto, Naoya ^a   Orita, Shin Ichiro ^a   Cui, Lin ^a   Sakakibara, Michihisa ^a   Shirai, Tomoyuki ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

CD44; Prostate cancer; Tumor differentiation

Indexed keywords

HERMES ANTIGEN; ISOPROTEIN;

ANTIGEN EXPRESSION; ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ANTIGENS, CD44; CELL DIFFERENTIATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC NEOPLASMS;

EID: 0032479556     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00088-3     Document Type: Article

References (27)

1. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics, 1997. CA Cancer J. Clin. 47:1997;2-27.
2. Underhill C. CD44: the hyaluronan receptor. J. Cell Sci. 103:1992;293-298.
3. Gunthert U. CD44: a multitude of isoforms with diverse functions. Curr. Top. Microbiol. Immunol. 184:1993;47-63.
4. Jackson D.G., Buckley J., Bell J.I. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J. Biol. Chem. 267:1992;4732-4739.
5. Screaton G.R., Bell M.V., Jackson D.G., Cornelis F.B., Gerth U., Bell J.I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA. 89:1992;12160-12164.
6. Screaton G.R., Bell M.V., Bell J.I., Jackson D.G. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor: comparison of all 10 variable exons between mouse, human, and rat. J. Biol. Chem. 268:1993;12235-12238.
7. Gunthert U., Hofmann M., Rudy W., Reber S., Zoller M., Haussmann I., Matzku S., Wenzel A., Ponta H., Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65:1991;13-24.
8. Mulder J.-W.R., Kruyt P.M., Sewnath M., Oosting J., Seldenrijk C.A., Weidema W.F., Offerhaus G.J.A., Pals S.T. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet. 344:1994;1470-1472.
9. Dall P., Heider K.-P., Sinn H.-P., Skroch-Angel P., Adolf G., Kaufmann M., Herrlich P., Ponta H. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int. J. Cancer. 60:1995;471-477.
10. Mayer B., Jauch K.W., Gunthert U., Figdor C.G., Schildberg F.W., Funke I., Johnson J.P. De-novo expression of CD44 and survival in gastric cancer. Lancet. 342:1993;1019-1022.
11. Friedrichs K., Franke F., Lisboa B.-W., Kugler G., Gille I., Terpe H.-J., Holzel F., Maass H., Gunthert U. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res. 55:1995;5424-5433.
12. Liu A.Y. Expression of CD44 in prostate cancer cells. Cancer Lett. 76:1994;63-69.
13. Welsh C.F., Zhu D., Bourguignon L.Y.W. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells. J. Cell Physiol. 164:1995;605-612.
14. Lokeshwar B.L., Lokeshwar V.B., Block N.L. Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential. Anticancer Res. 15:1995;1191-1198.
15. Stevens J.W., Palechek P.L., Griebling T.L., Midura R.J., Rokhlin O.W., Cohen M.B. Expression of CD44 isoforms in human prostate tumor cell lines. Prostate. 28:1996;153-161.
16. Wielenga V.J.M., Heider K.-H., Offerhaus G.J.A., Adolf G.R., van den Berg F.M., Ponta H., Herrlich P., Pals S.T. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res. 53:1993;4754-4756.
17. Washington K., Gottfried M.R., Telen M.J. Expression of cell adhesion molecule CD44 in gastric adenocarcinomas. Hum. Pathol. 25:1994;1043-1049.
18. Terpe H.-J., Storkel S., Zimmer U., Anquez V., Fischer C., Pantel K., Gunthert U. Expression of CD44 isoforms in renal cell tumors: positive correlation to tumor differentiation. Am. J. Pathol. 148:1996;453-463.
19. Terpe H.-J., Koopmann R., Imhof B., Gunthert U. Expression of integrins and CD44 in non-Hodgkin's lymphomas: CD44 variants are preferentially expressed in high-grade malignant lymphomas. J. Pathol. 174:1994;89-100.
20. Fujita N., Yaegashi N., Ide Y., Sato S., Nakamura M., Ishikawa I., Yajima A. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res. 54:1994;3922-3928.
21. Sugino T., Gorham H., Yoshida K., Bolodeoku J., Nargund V., Cranston D., Goodison S., Tarin D. Progressive loss of CD44 gene expression in invasive bladder cancer. Am. J. Pathol. 149:1996;873-882.
22. Mackay C.R., Terpe H.-J., Stauder R., Marston W.L., Stark H., Gunthert U. Expression and modulation of CD44 variant isoforms in humans. J. Cell Biol. 124:1994;71-82.
23. Fox S.B., Fawcett J., Jackson D.G., Collins I., Gatter K.C., Harris A.L., Gearing A., Simmons D.L. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res. 54:1994;4539-4546.
24. Kallakury B.V.S., Yang F., Figge J., Smith K., Kausik S.J., Tacy N.J., Fisher H.A.G., Kaufman R., Figge H., Ross J.S. Decreased levels of CD44 protein and mRNA in prostate carcinoma: correlation with tumor grade and ploidy. Cancer. 78:1996;1461-1469.
25. Iczkowski K.A., Pantazis C.G., Collins J. The loss of expression of CD44 standard and variant isoforms is related to prostatic carcinoma development and tumor progression. J. Urol. Pathol. 6:1997;119-129.
26. Epstein J.I., Pizov G., Walsh P.C. Correlation of pathologic findings with progression following radical retropubic prostatectomy. Cancer. 71:1993;3582-3593.
27. Gao A.C., Lou W., Dong J.-T., Isaacs J.T. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res. 57:1997;846-849.